Express Diagnostics Int'l, Inc.

P.O. Box 310, 56013 Blue Earth, MN
1550 Industrial Drive, 56013 Blue Earth, MN

Telephone +1 507 5263951
Fax +1 507 5262252


Hall map

MEDICA 2016 hall map (Hall 1): stand C35

Fairground map

MEDICA 2016 fairground map: Hall 1

Our range of products

Product categories

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.11  Drugs of abuse / Toxicology

Our products

Product category: Drugs of abuse / Toxicology

onsite screens for drugs of abuse

DrugCheck® onsite screening devices are well known in the industry for easy-to-read devices that incorporate single drug, color-coded test strips. All DrugCheck urine test cups, dips, and the SalivaScan™ oral fluid drug test use common color coding for quick recognition of individual drug strips.

Express Diagnostics offers devices and configurations specifically for the international market, including custom drug cutoffs for urinalysis and saliva.
• Multiple drugs and cutoffs available
• cGMP compliant, ISO 13485:2003-certified manufacturer
• CE certified

More Less

Product category: Drugs of abuse / Toxicology

DrugCheck® Dip Drug Test

Express Diagnostics offers single- and multiple-drug dip test devices, as well as single test strips. The DrugCheck Dip Drug Test is a rapid, qualitative immunoassay for the detection of up to 14 drugs of abuse in a convenient, one-step test. Simply dip test strips in urine sample for 15 seconds and read results at 5 minutes.

Dip Drug Test 510(k) cleared for 17 drugs of abuse

The DrugCheck Dip Drug Test is available in configurations of up to 14 drugs and/or adulterants, including the following 510(k) cleared drugs:
•Cocaine (150 and 300 ng/mL)
•Methamphetamine (500 and 1000 ng/mL)
•Opiates (300 and 2000 ng/mL)
•Tricyclic Antidepressants

More Less

Product category: Drugs of abuse / Toxicology

DrugCheck® NxScan Cup

One of the easiest to use onsite testing products on the market now comes in a flat panel cup for easy copying or scanning for a permanent record. The NxScan collection cup and testing device delivers instant, accurate results and process convenience, including a ‘lay flat’ design for improved record-keeping. The NxScan self-contained urinalysis screening device detects the presence of drug metabolites in minutes.

More Less

Product category: Drugs of abuse / Toxicology

DrugCheck® SalivaScan™

The DrugCheck® SalivaScan™ oral fluid drug test includes the first sponge saturation indicator on the market. No more throwing away devices due to inadequate specimen in the saliva drug test. The indicator strip in the collection swab changes color once the sponge contains enough saliva. The swab locks into the device for a tamper evident and airtight seal.

Saliva drug screening features:
• Sponge saturation indicator (Patent Pending)
• Market-leading drug cutoffs – No buffer required◦Buprenorphine: 5 ng/ml
• Cotinine: 50 ng/ml
• EDDP: 20 ng/ml
• Ketamine: 50 ng/ml
• Methadone: 30 ng/ml

• 100% tamper-evident with sample held in airtight chamber for confirmation
• Detect up to 10 drugs including alcohol
• One drug per strip for superior accuracy
• Extraction ports for lab confirmation

More Less

About us

Company details

Express Diagnostics Int’l, Inc. (EDI), manufactures and distributes DrugCheck® onsite urine and saliva screening devices for the detection of drugs of abuse, as well as a growing line of rapid alcohol screening and health diagnostics devices. With accuracy comparable to laboratory testing, Express Diagnostics Int'l onsite devices provide a variety of industries fast, cost-effective alternatives to higher-priced lab services.

As an ISO 13485:2003-certified and FDA-registered manufacturer, EDI also offers complete OEM services for private label device manufacturing. Comprehensive in-house marketing, design, and short-run production capabilities speed the private-label development process and reduce costs for distributors.

Founded in 2004 with five employees, Express Diagnostics Int'l is based in Blue Earth, Minn., and has distribution partners in more than 60 countries. EDI also has company representatives in California, Colorado, Massachusetts, and Sofia, Bulgaria.

EDI was honored to be named to the 2013, 2014, and 2015 Inc. 5000 lists of fastest-growing companies in the U.S.A.

Express Diagnostics Global, Ltd. (EDG) was formed in March 2015 as a subsidiary of EDI to service a growing customer base for drugs of abuse screening devices in the EMEA region (Europe, Middle East, and Africa). The planned additional production capacity and EU-based customer service available through EDG, based in Sofia, Bulgaria, offers several advantages, including shorter product lead times for all EDI customers, and faster, lower-cost shipping to EMEA customers. Manufacturing in Bulgaria is scheduled to begin in January 2016.

DrugCheck devices are made in the U.S.A. Sold through a worldwide distributor network since 2002, DrugCheck continues to build on its consistent growth in IVD point-of-care testing. Learn more at

More Less

Company data

Sales volume

10-49 Mio US $

Export content

max. 50%

Number of employees




Area of business